SG Americas Securities LLC Has $5.11 Million Position in Amedisys, Inc. (NASDAQ:AMED)

SG Americas Securities LLC lessened its holdings in Amedisys, Inc. (NASDAQ:AMED) by 71.4% in the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 56,254 shares of the health services provider’s stock after selling 140,459 shares during the period. SG Americas Securities LLC owned about 0.17% of Amedisys worth $5,107,000 as of its most recent SEC filing.

A number of other institutional investors and hedge funds have also modified their holdings of AMED. Dimensional Fund Advisors LP grew its stake in Amedisys by 4.0% during the 2nd quarter. Dimensional Fund Advisors LP now owns 514,166 shares of the health services provider’s stock valued at $47,202,000 after acquiring an additional 19,660 shares in the last quarter. Vanguard Personalized Indexing Management LLC grew its position in Amedisys by 12.9% during the second quarter. Vanguard Personalized Indexing Management LLC now owns 5,421 shares of the health services provider’s stock valued at $498,000 after purchasing an additional 619 shares in the last quarter. Intech Investment Management LLC acquired a new position in Amedisys in the 2nd quarter valued at approximately $280,000. Bank of Montreal Can lifted its position in Amedisys by 146.4% in the 2nd quarter. Bank of Montreal Can now owns 10,429 shares of the health services provider’s stock worth $966,000 after buying an additional 6,197 shares in the last quarter. Finally, Squarepoint Ops LLC boosted its stake in shares of Amedisys by 72.8% during the 2nd quarter. Squarepoint Ops LLC now owns 64,947 shares of the health services provider’s stock valued at $5,962,000 after buying an additional 27,353 shares during the period. Hedge funds and other institutional investors own 94.36% of the company’s stock.

Amedisys Trading Up 0.2 %

Amedisys stock opened at $92.80 on Friday. The company has a quick ratio of 1.19, a current ratio of 1.19 and a debt-to-equity ratio of 0.05. Amedisys, Inc. has a 12 month low of $82.15 and a 12 month high of $98.95. The company’s fifty day simple moving average is $89.17 and its 200-day simple moving average is $94.20. The stock has a market cap of $3.04 billion, a P/E ratio of 36.83, a P/E/G ratio of 1.83 and a beta of 0.72.

Amedisys (NASDAQ:AMED) last issued its earnings results on Wednesday, November 6th. The health services provider reported $1.00 earnings per share for the quarter, missing the consensus estimate of $1.19 by ($0.19). Amedisys had a return on equity of 12.20% and a net margin of 3.57%. The firm had revenue of $587.67 million during the quarter, compared to analyst estimates of $586.75 million. During the same period in the previous year, the company earned $0.98 earnings per share. The business’s revenue for the quarter was up 5.7% on a year-over-year basis. As a group, sell-side analysts forecast that Amedisys, Inc. will post 4.43 EPS for the current fiscal year.

About Amedisys

Amedisys, Inc, together with its subsidiaries, provides healthcare services in the United States. It operates through three segments: Home Health, Hospice, and High Acuity Care. The Home Health segment offers a range of services in the homes of individuals for the recovery of patients from surgery, chronic disability, or terminal illness, as well as prevents avoidable hospital readmissions through its skilled nurses; nursing services, rehabilitation therapists specialized in physical, speech, and occupational therapy; and social workers and aides for assisting its patients.